059: Identification of novel subtype-specific alterations as candidates for drug targets and characterization of intratumour genetic heterogeneity and its contribution to therapy resistance in high-grade serous ovarian cancer (HGSOC)

HIPO Investigator:

PD Dr. Frederik Marmé

Dr. Marc Zapatka

Prof. Dr. Peter Lichter

Dr. Martin Sprick

Prof. Dr. Andreas Trumpp

Prof. Peter Sinn

Dr. Monika Hämmerle

Prof. Dr. Barbara Burwinkel

Prof. Dr. Andreas Schneeweiss

Prof. Dr. Benedikt Brors

 

Entity: HGSOC

DKFZ Logo 3zu Research en Black Blue sRGB

4c nctlogo 2009

We use cookies on our website. Some of them are essential for the operation of the site, while others help us to improve this site and the user experience (tracking cookies). You can decide for yourself whether you want to allow cookies or not. Please note that if you reject them, you may not be able to use all the functionalities of the site.